{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:03:06Z","timestamp":1791295386248,"version":"4.1.0"},"reference-count":83,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,4]]},"abstract":"<jats:p>Current regulations stipulate a yellow fever (YF) booster every 10 years. We conducted a systematic review of the protective efficacy and duration of immunity of YF vaccine in residents of disease-endemic areas and in travelers to assess the need for a booster in these two settings and in selected populations (human immunodeficiency virus\u2013infected persons, infants, children, pregnant women, and severely malnourished persons). Thirty-six studies and 22 reports were included. We identified 12 studies of immunogenicity, 8 of duration of immunity, 8 of vaccine response in infants and children, 7 of human-immunodeficiency virus\u2013infected persons, 2 of pregnant women, and 1 of severely malnourished children. Based on currently available data, a single dose of YF vaccine is highly immunogenic and confers sustained life-long protective immunity against YF. Therefore, a booster dose of YF vaccine is not needed. Special considerations for selected populations are detailed.<\/jats:p>","DOI":"10.4269\/ajtmh.13-0264","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T15:55:57Z","timestamp":1378310157000},"page":"434-444","source":"Crossref","is-referenced-by-count":227,"title":["Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years"],"prefix":"10.4269","volume":"89","author":[{"given":"Eduardo","family":"Gotuzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Yactayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Lancet Infect Dis","first-page":"622","article-title":"The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever","volume":"11","author":"Jentes","year":"2011"},{"key":"R2","series-title":"Curr Infect Dis Rep","first-page":"34","article-title":"Yellow fever immunizations: indications and risks","volume":"6","author":"Wilson","year":"2004"},{"key":"R3","series-title":"Vaccine","first-page":"2758","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007"},{"key":"R4","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010"},{"key":"R5","series-title":"Am J Trop Med Hyg","first-page":"359","article-title":"The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice","volume":"78","author":"Wilder-Smith","year":"2008"},{"key":"R6","series-title":"J Med Virol","first-page":"159","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998"},{"key":"R7","series-title":"Rev Salud Publica (Bogota)","first-page":"796","article-title":"Yellow fever virus 17D neutralizing antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue [in Spanish]","volume":"10","author":"Gomez","year":"2008"},{"key":"R8","series-title":"Bull World Health Organ","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 year(s) after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962"},{"key":"R9","series-title":"Bull World Health Organ","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 year(s) after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981"},{"key":"R10","series-title":"Am J Trop Med Hyg","first-page":"739","article-title":"Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil","volume":"85","author":"de Melo","year":"2011"},{"key":"R11","series-title":"Am J Trop Med Hyg","first-page":"230","article-title":"Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963"},{"key":"R12","series-title":"Trop Med Int Health","first-page":"867","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999"},{"key":"R13","series-title":"Bull Soc Pathol Exot","first-page":"260","article-title":"Long term persistence of yellow fever neutralizing antibodies in elderly persons [in French]","volume":"104","author":"Coulange Bodilis","year":"2011"},{"key":"R14","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"130","article-title":"Transmission of yellow fever vaccine virus through breast-feeding\u2013Brazil, 2009","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010"},{"key":"R15","series-title":"CMAJ","first-page":"E243","article-title":"Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk","volume":"183","author":"Kuhn","year":"2011"},{"key":"R16","series-title":"Wkly Epidemiol Rec","first-page":"38","article-title":"Meeting of the Global Advisory Committee on Vaccine Safety, December 2010","volume":"86","author":"Anonymous","year":"2011"},{"key":"R17","series-title":"J Med Assoc Thai","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002"},{"key":"R18","series-title":"Appl Microbiol","first-page":"908","article-title":"Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine","volume":"23","author":"Mason","year":"1972"},{"key":"R19","series-title":"Appl Microbiol","first-page":"539","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973"},{"key":"R20","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010"},{"key":"R21","series-title":"Vaccine","first-page":"6008","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011"},{"key":"R22","series-title":"Vaccine","first-page":"5205","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005"},{"key":"R23","series-title":"Expert Rev Vaccines","first-page":"553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005"},{"key":"R24","series-title":"Vaccine","first-page":"2843","article-title":"Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006"},{"key":"R25","series-title":"Rev Invest (Guadalajara)","first-page":"5","article-title":"Observations on the 17 D virus vaccine against yellow fever, applied by cutaneous scarification [in Spanish]","volume":"5","author":"Groot","year":"1965"},{"key":"R26","series-title":"Rev Panam Salud Publica","first-page":"115","article-title":"Effectiveness of the yellow fever vaccine 17D: an epidemiologic evaluation in health services [in Spanish]","volume":"2","author":"Guerra","year":"1997"},{"key":"R27","series-title":"J Virol Methods","first-page":"179","article-title":"MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination","volume":"110","author":"Vazquez","year":"2003"},{"key":"R28","series-title":"Rev Saude Publica","first-page":"671","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004"},{"key":"R29","series-title":"Rev Soc Bras Med Trop","first-page":"1","article-title":"Serologic survey for yellow fever and other arboviruses among inhabitants of Rio Branco, Brazil, before and three months after receiving the yellow fever 17D vaccine [in Portuguese]","volume":"37","author":"Tavares-Neto","year":"2004"},{"key":"R30","series-title":"Am J Trop Med Hyg","first-page":"189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005"},{"key":"R31","series-title":"Am J Trop Med Hyg","first-page":"339","article-title":"Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005"},{"key":"R32","series-title":"Vaccine","first-page":"1421","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","author":"Suzano","year":"2006"},{"key":"R33","series-title":"Am J Trop Med Hyg","first-page":"533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002"},{"key":"R34","series-title":"Lancet Infect Dis","first-page":"11","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001"},{"key":"R35","series-title":"Clin Vaccine Immunol","first-page":"177","article-title":"Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus","volume":"15","author":"Niedrig","year":"2008"},{"key":"R36","series-title":"Am J Trop Med Hyg","first-page":"570","article-title":"Immunological studies with group B arthropod-borne viruses. III. Response of human subjects to revaccination with 17D strain yellow fever vaccine","volume":"11","author":"Wisseman","year":"1962"},{"key":"R37","series-title":"Comp Immunol Microbiol Infect Dis","first-page":"95","article-title":"Yellow fever haemagglutination-inhibiting, neutralising and IgM antibodies in vaccinated and unvaccinated residents of Ibadan, Nigeria","volume":"13","author":"Omilabu","year":"1990"},{"key":"R38","series-title":"J Virol","first-page":"8004","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jordan","year":"2005"},{"key":"R39","series-title":"Clin Diagn Lab Immunol","first-page":"302","article-title":"Lymphocytic 2\u2032,5\u2032-oligoadenylate synthetase activity increases prior to the appearance of NTAbs and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine","volume":"2","author":"Bonnevie-Nielsen","year":"1995"},{"key":"R40","series-title":"Med Mal Infect","first-page":"524","article-title":"Yellow fever vaccination in non-immunocompetent patients [in French]","volume":"38","author":"Bruyand","year":"2008"},{"key":"R41","series-title":"Vaccine","first-page":"4544","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review","volume":"29","author":"Thomas","year":"2011"},{"key":"R42","series-title":"Rev Med Interne","first-page":"554","article-title":"Antiviral immunization of immunocompromised adults, literature review [in French]","volume":"29","author":"Duchet Niedziolka","year":"2008"},{"key":"R43","series-title":"Am J Trop Med Hyg","first-page":"57","article-title":"Immunity to yellow fever 6 year(s) after vaccination","volume":"29","author":"Dick","year":"1949"},{"key":"R44","series-title":"Am J Hyg","first-page":"302","article-title":"Immunity to yellow fever five year(s) after vaccination","volume":"45","author":"Anderson","year":"1947"},{"key":"R45","series-title":"Am J Hyg","first-page":"64","article-title":"Additional observations on the duration of humoral immunity following vaccination with the 17D strain of yellow fever virus","volume":"47","author":"Fox","year":"1948"},{"key":"R46","series-title":"Vaccine","first-page":"6478","article-title":"Yellow fever vaccination coverage among children in Brazilian capitals","volume":"28","author":"Veras","year":"2010"},{"key":"R47","series-title":"J Biol Stand","first-page":"77","article-title":"Studies on yellow fever vaccine. III. Dose response in volunteers","volume":"16","author":"Lopes","year":"1988"},{"key":"R48","series-title":"Vaccine","first-page":"1042","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano","year":"1999"},{"key":"R49","series-title":"Clin Infect Dis","first-page":"7","article-title":"Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases","volume":"31","author":"Receveur","year":"2000"},{"key":"R50","series-title":"AIDS","first-page":"825","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","author":"Tattevin","year":"2004"},{"key":"R51","series-title":"Curr HIV Res","first-page":"461","article-title":"Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients","volume":"8","author":"Pistone","year":"2010"},{"key":"R52","series-title":"Trans R Soc Trop Med Hyg","first-page":"437","article-title":"Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali","volume":"106","author":"Sidibe","year":"2012"},{"key":"R53","series-title":"Pediatr Infect Dis J","first-page":"1177","article-title":"Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1","volume":"16","author":"Sibailly","year":"1997"},{"key":"R54","series-title":"Clin Infect Dis","first-page":"659","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Veit","year":"2009"},{"key":"R55","series-title":"J Acquir Immune Defic Syndr","first-page":"360","article-title":"Plasma HIV-RNA is the key determinant of long-term antibody persistence after yellow fever immunization in a cohort of 364 HIV-infected patients","volume":"59","author":"Pacanowski","year":"2012"},{"key":"R56","series-title":"Trans R Soc Trop Med Hyg","first-page":"337","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","author":"Nasidi","year":"1993"},{"key":"R57","series-title":"Trop Geogr Med","first-page":"125","article-title":"Failure of antibody production to yellow fever vaccine in children with kwashiorkor","volume":"18","author":"Brown","year":"1966"},{"key":"R58","series-title":"Nutr Rev","first-page":"108","article-title":"Effects of malnutrition on smallpox and yellow fever vaccination","volume":"25","author":"Anonymous","year":"1967"},{"key":"R59","series-title":"Vaccines","first-page":"870","article-title":"Yellow fever","author":"Monath","year":"2012"},{"key":"R60","series-title":"Am J Trop Med Hyg","first-page":"175","article-title":"Antibodies to yellow fever and other arthropod-borne viruses in human residents of San Vicente de Chucuri, Santander, Colombia","volume":"8","author":"Groot","year":"1959"},{"key":"R61","series-title":"J Exp Med","first-page":"3119","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008"},{"key":"R62","series-title":"Wkly Epidemiol Rec","first-page":"33","article-title":"Yellow fever fact sheet","volume":"85","author":"Anonymous","year":"2010"},{"key":"R63","series-title":"Am J Epidemiol","first-page":"187","article-title":"Herd immunity: basic concept and relevance to public health immunization practices","volume":"141","author":"Fox","year":"1995"},{"key":"R64","series-title":"J Travel Med","article-title":"Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus","volume":"2","author":"Goujon","year":"1995"},{"key":"R65","article-title":"Antibody response and safety of yellow fever vaccination in HIV infected patients","author":"Pacanowski","year":"2008"},{"key":"R66","series-title":"Wkly Epidemiol Rec","first-page":"181","article-title":"Expanded programme on immunization (EPI). Inclusion of yellow fever vaccine in the EPI","volume":"71","author":"Anonymous","year":"1996"},{"key":"R67","series-title":"Bull Soc Pathol Exot","first-page":"341","article-title":"Yellow fever as an endemic\/epidemic disease and priorities for vaccination","volume":"99","author":"Monath","year":"2006"},{"key":"R68","series-title":"Am J Trop Med","first-page":"233","article-title":"Observations on the age and sex incidence of deaths and recoveries in the yellow fever epidemic in the department of Lambayeque, Peru, in 1921","volume":"9","author":"Hanson","year":"1929"},{"key":"R69","series-title":"Am J Trop Med Hyg","first-page":"912","article-title":"Yellow fever in the Gambia, 1978\u20131979: epidemiologic aspects with observations on the occurrence of Orungo virus infections","volume":"29","author":"Monath","year":"1980"},{"key":"R70","series-title":"Lancet","first-page":"451","article-title":"H1N1 2009 influenza virus infection during pregnancy in the USA","volume":"374","author":"Jamieson","year":"2009"},{"key":"R71","series-title":"Obstet Gynecol","first-page":"983","article-title":"Hepatitis B vaccination in pregnancy: factors influencing efficacy","volume":"93","author":"Ingardia","year":"1999"},{"key":"R72","series-title":"Trop Med Int Health","first-page":"29","article-title":"Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study","volume":"3","author":"Nishioka","year":"1998"},{"key":"R73","series-title":"Trop Med Int Health","first-page":"833","article-title":"Early exposure to yellow fever vaccine during pregnancy","volume":"12","author":"Cavalcanti","year":"2007"},{"key":"R74","series-title":"Trans R Soc Trop Med Hyg","first-page":"231","article-title":"Yellow fever in the recently inoculated","volume":"38","author":"Elliot","year":"1944"},{"key":"R75","series-title":"East Afr Med J","first-page":"1","article-title":"A fatal case of yellow fever in a European in Uganda","volume":"30","author":"Ross","year":"1953"},{"key":"R76","series-title":"Lancet","first-page":"1275","article-title":"Imported yellow fever in vaccinated tourist","volume":"334","author":"Nolla-Salas","year":"1989"},{"key":"R77","series-title":"Trans R Soc Trop Med Hyg","first-page":"169","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998\u20132002","volume":"101","author":"Tuboi","year":"2007"},{"key":"R78","series-title":"Clin Infect Dis","first-page":"1143","article-title":"Imported yellow fever in a United States citizen","volume":"25","author":"McFarland","year":"1997"},{"key":"R79","series-title":"Lancet","first-page":"969","article-title":"Jungle yellow fever in the central Amazon","volume":"348","author":"Barros","year":"1996"},{"key":"R80","series-title":"J Clin Virol","first-page":"274","article-title":"Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium","volume":"33","author":"Bae","year":"2005"},{"key":"R81","series-title":"Wkly Epidemiol Rec","first-page":"322","article-title":"Yellow fever, 1998\u20131999","volume":"75","author":"Anonymous","year":"2000"},{"key":"R82","series-title":"Clin Infect Dis","first-page":"e113","article-title":"A Belgian traveller who acquired yellow fever in the Gambia","volume":"35","author":"Colebunders","year":"2002"},{"key":"R83","series-title":"JAMA","first-page":"2499","article-title":"Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002","volume":"287","author":"Centers for Disease Control and Prevention","year":"2002"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/89\/3\/article-p434.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/89\/3\/article-p434.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/89\/3\/article-p434.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:24:51Z","timestamp":1723040691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/89\/3\/article-p434.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,4]]},"references-count":83,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.13-0264","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718099395.793484204","asserted-by":"object"}]},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,4]]}}}